금정제약(주)

02R&D

제품정보

R&D

연구분야 파이프라인 논문

R&D 논문

논문

Structural basis of the oncogenic KRAS mutant and GJ101 complex, Biochemical and Biophysical Research Communications. (2023)

조회수 358

Structural basis of the oncogenic KRAS mutant and GJ101 complex, Biochemical and Biophysical Research Communications. (2023)

이전글 Structural study of novel vaccinia virus E3L and dsRNA-dependent proteinkinase complex, Biochemical and Biophysical Research Communications. (2023)
다음글 DED Interaction of FADD and Caspase-8 in the Induction of Apoptotic Cell Death, J Microbiol Biotechnol. (2022)

개인정보처리방침 이메일무단수집거부

회사명 : 금정제약(주)

대표 : 정미숙

주소 : 서울특별시 영등포구 국회대로66길 23

TEL : 02-784-2544

FAX : 02-784-2545

Copyright© 금정제약(주). All Rights Reserved.